Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantationBruno Paiva, Jesús F. San Miguel, María Ángeles Montalbán et al.|Blood|2008Cited by 479
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple MyelomaJuan‐José Garcés, Bruno Paiva, María‐Teresa Cedena et al.|Journal of Clinical Oncology|2022Cited by 114
The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patientsBruno Paiva, María‐Belén Vídriales, Gema Mateo et al.|Blood|2009Cited by 75